Sarepta Therapeutics (SRPT) option implied volatility elevated

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. RNG
2. DECK
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. TSCO
9. BE
10. IVBIY

Go back to Sarepta Therapeutics (SRPT) option implied volatility elevated

Evercore on Sarepta (SRPT) Post Stat News Article: 'probably sets up for the adcomm briefing documents and tone to be somewhat more negative'

April 13, 2023 10:39 AM EDT

Evercore ISI analyst Gavin Clark-Gartner reiterated an Outperform rating and $149.00 price target on Sarepta Therapeutics (NASDAQ: SRPT).

The analyst comments "The STAT article from this morning (HERE) is a must-read. To briefly summarize: the market had thought SRPTs... More